TG Therapeutics | TGTX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -6.66B 3.39B 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 9.19B 532M 2026-03
Ardelyx USD 148.62M 18.33M 2026-03
Arrowhead Research USD 613.98M 45.56M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Curis USD 5.46M 19.45M 2025-12
Gilead Sciences USD 23.52B 897M 2026-03
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
J&J USD 81.19B 358M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Novavax USD -144.76M 17.01M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
TG Therapeutics USD 583.13M 64.89M 2026-03
Verastem USD 57.2M 72.72M 2025-12
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03